The global market for GLP-1 drugs is around $72 billion and likely to double by 2030, analysts estimated, but Novos lead has evaporated and it has been forced into a price war.
The FDA had issued a Black Box Warning in 2004 about this risk, and subsequent lawsuits have claimed that Pfizer failed to provide adequate warnings to consumers and healthcare providers
Typically, patients would have to have formal diagnostic tests to prove that they experienced one of these complications from Ozempic
Typically, patients are started on a lower dosage and as your doctor receives feedback on your progress they may increase your dosage
Why Branded GLP-1s Can Be Expensive Branded products carry additional layers that compound costs: patented manufacturing processes, specialized packaging such as auto-inject pens, and supply bottlenecks that allow manufacturers and distributors to influence availability
Try not to skip meals and allow time for digestion between meals